Point72 Europe »

Syndax Pharmaceuticals shares owned by Point72 Europe

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Point72 Europe from 13F filings

Historical chart of Point72 Europe investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Point72 Europe consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Point72 Europe

Quarter filed Position value Share count Share price at filing
2025-03-31 $2.3M 185k 12.29

More positions owned by Point72 Europe

Strategy Cl A New (MSTR)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Capital One Financial (COF)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Key (KEY)
Charles Schwab Corporation (SCHW)
TPG Com Cl A (TPG)
WESCO International (WCC)
Bank of America Corporation (BAC)
Regeneron Pharmaceuticals (REGN)
Suncor Energy (SU)
Linde SHS (LIN)

View all positions for Point72 Europe

Top funds holding Syndax Pharmaceuticals

BlackRock
Kynam Capital Management
Goldman Sachs Group
Vanguard Group
Point72 Asset Management
State Street Corporation
Eversept Partners
Adage Capital Partners GP
Kingdon Capital Management
Franklin Resources
Geode Capital Management
Soleus Capital Management
UBS Group
Qube Research & Technologies
Catalio Capital Management

View all funds holding Syndax Pharmaceuticals